DEEPTECH.INTEL

About Deep Tech Intel

Mission

Deep Tech Intel exists to make the world's most consequential technologies understandable, trackable, and accessible. We believe that the technologies being built today in robotics labs, neuroscience clinics, quantum research facilities, nuclear startups, and synthetic biology foundries will define the next century.

Yet information about these fields is fragmented across academic papers, press releases, regulatory filings, and social media. Deep Tech Intel consolidates this information into five dedicated intelligence platforms — each a Bloomberg Terminal-style dashboard for its sector — updated continuously by autonomous AI agents.

This parent site aggregates data across all five sectors, providing the macro view of the deep tech landscape: cross-sector funding trends, a unified company directory, and quarterly analysis of where capital and talent are flowing.

The Network

HUMANOID.INTELhttps://humanoidintel.ai
Humanoid Robotics intelligence platform — company tracking, funding rounds, news, research, and glossary.
BCI.INTELhttps://bciintel.com
Brain-Computer Interfaces intelligence platform — company tracking, funding rounds, news, research, and glossary.
QUANTUM.INTELhttps://quantumintel.tech
Quantum Computing intelligence platform — company tracking, funding rounds, news, research, and glossary.
SMR.INTELhttps://smrintel.com
Small Modular Reactors intelligence platform — company tracking, funding rounds, news, research, and glossary.
SYNBIO.INTELhttps://synbiointel.com
Synthetic Biology intelligence platform — company tracking, funding rounds, news, research, and glossary.

Editorial Approach

Each sector platform runs an autonomous AI agent that continuously scans RSS feeds, news sources, arXiv preprints, government databases, and industry publications. Incoming signals are scored for relevance and significance, deduplicated across four layers, then transformed into structured intelligence articles.

Company directories, funding databases, and device specifications are curated from primary sources including SEC filings, FDA databases, ClinicalTrials.gov, and company announcements. All data is attributed and timestamped.

The quarterly State of Deep Tech reports and weekly Deep Tech Dispatch newsletter are human-edited, providing analysis and context that complements the automated intelligence feeds.

Contact

For corrections, partnerships, or press inquiries, reach us on X at @DeepTechIntel.